Clinical cancer advances 2012: Annual report on progress against cancer from the American Society of Clinical Oncology Journal Article
| Authors: | Roth, B. J.; Krilov, L.; Adams, S.; Aghajanian, C. A.; Bach, P.; Braiteh, F.; Brose, M. S.; Ellis, L. M.; Erba, H.; George, D. J.; Gilbert, M. R.; Jacobson, J. O.; Larsen, E. C.; Lichtman, S. M.; Partridge, A. H.; Patel, J. D.; Quinn, D. I.; Robison, L. L.; Von Roenn, J. H.; Samlowski, W.; Schwartz, G. K.; Vogelzang, N. J. |
| Article Title: | Clinical cancer advances 2012: Annual report on progress against cancer from the American Society of Clinical Oncology |
| Keywords: | cancer survival; treatment response; leukemia; acute granulocytic leukemia; overall survival; lenalidomide; fluorouracil; advanced cancer; cancer growth; diarrhea; side effect; unspecified side effect; united states; conference paper; cancer radiotherapy; glioma; antineoplastic agent; cancer diagnosis; endometrium cancer; colorectal cancer; gastrointestinal stromal tumor; imatinib; unindexed drug; cancer immunotherapy; cancer prevention; melanoma; progression free survival; bortezomib; multiple myeloma; ovary cancer; breast cancer; basal cell carcinoma; lung non small cell cancer; aromatase inhibitor; weight reduction; cancer screening; smoking; stem cell transplantation; food and drug administration; chronic myeloid leukemia; oncology; cetuximab; cancer research; kidney carcinoma; acute lymphoblastic leukemia; childhood cancer; cancer resistance; docetaxel; exemestane; irinotecan; protein tyrosine kinase inhibitor; prostate cancer; sarcoma; vincristine sulfate; hematologic malignancy; neuroblastoma; folinic acid; colon cancer; uterine cervix cancer; aflibercept; pazopanib; medical society; soft tissue sarcoma; liver cancer; oligodendroglioma; large cell lymphoma; kidney cancer; axitinib; trastuzumab; mammalian target of rapamycin inhibitor; alcohol consumption; esophagus cancer; chronic lymphatic leukemia; everolimus; mouth cancer; lapatinib; pertuzumab; muscle cramp; carfilzomib; drug indication; hair loss; castration resistant prostate cancer; head and neck squamous cell carcinoma; thyroid medullary carcinoma; adult disease; vismodegib; crizotinib; cabozantinib; enzalutamide; ibrutinib; ponatinib; regorafenib |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 1 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-01-01 |
| Start Page: | 131 |
| End Page: | 161 |
| Language: | English |
| DOI: | 10.1200/jco.2012.47.1938 |
| PROVIDER: | scopus |
| PUBMED: | 23213095 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 1 February 2013" - "CODEN: JCOND" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
385Schwartz -
228Lichtman -
255Bach -
607Aghajanian
Related MSK Work